Suggestions
John Maher
Consultant in Immunology specializing in Cell Therapy
John Maher is a clinically active Physician Immunologist with extensive experience in the research industry, specializing in immunotherapy and immunopathology.
He is known for being the first to engineer and develop CD28-based second generation CAR technology in human T-cells, with over twenty years of experience in pre-clinical and clinical development of CAR T cell immunotherapy.
John Maher served as the chief investigator of a CAR-T Phase I clinical trial for refractory head and neck cancer.
His educational background includes a PhD in Medicine from the University of London, an MSc in Immunology with Distinction from the University of London, and various degrees in Medicine and Biochemistry from prestigious institutions like Trinity College Dublin.
He holds the FRCPath in Immunology from the Royal College of Pathologists and is registered on the General Medical Council specialist register of Clinical Immunologists.
Throughout his career, John Maher has held significant roles in organizations such as Eastbourne Hospital, King's College London, Leucid Bio, and the Royal Free NHS Foundation Trust.
